18F-FDG PET/CT for staging Hodgkin lymphoma may allow for accurate and reliable
assessment of the metabolic tumor volume (MTV) as a baseline risk factor. Our aim was to …

Purpose The presence of a bulky tumour at staging in Hodgkin lymphoma (HL) is a predictor
of a poor outcome. The total metabolic tumour volume at baseline (TMTV0) computed on …

Abstract Background 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)
plays an important role in the staging and response assessment of lymphoma patients. Our …

Aim: Although it is not yet used in clinical practice, metabolic tumor volume (MTV) assessed
on the baseline FDG-PET has shown consistent prognostic value in various lymphoma …

Aim To investigate the respective influence of software tool and total metabolic tumor volume
(TMTV0) calculation method on prognostic stratification of baseline 2-deoxy-2-[18F] fluoro-D …

We tested baseline positron emission tomography (PET)/computed tomography (CT) as a
measure of total tumor burden to better identify high-risk patients with early-stage Hodgkin …

Identification of prognostic factors for patients with relapsed/refractory Hodgkin lymphoma
(HL) is essential for optimizing therapy with risk-adapted approaches. In our phase 2 study …

Recent studies have shown that metabolic tumor volume (MTV) by positron emission
tomography/computed tomography (PET/CT) is an important prognostic parameter in …

The presence of bulky disease in Hodgkin lymphoma (HL), traditionally defined with a 1-
dimensional measurement, can change a patient's risk grouping and thus the treatment …

Purpose To systematically review the literature evaluating clinical utility of imaging metrics
derived from baseline fluorine-18 fluorodeoxyglucose positron emission …